Document Type : Research Paper
Noncommunicable Disease Research Center, Fasa University of Medical Sciences, Fasa, Iran
Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran
Noncommunicable Disease Research Center, Fasa University of Medical Sciences, Fasa, Iran;Medicinal Plants Research Center, Fasa University of Medical Sciences, Fasa, Iran
Free radicals impair the cellular and tissue homeostasis, which can cause cancer. Hypnea musiformis is a red seaweed and rich source of secondary antioxidant metabolites. These metabolites probably are effective in cancer treatment. In the present study, the phenolic and flavonoid content of the hydro-methanolic extract of Hypnea musiformis were determined respectively by the Folin-Ciocalteu and aluminum-chloride assay. The monovalent reducing power and total radical scavenging activity of the extract were also evaluated respectively by FRAP and DPPH assay. The cytotoxic effects of the extract were evaluated by MTT assay on MDA-MB-231 and MCF7 cell lines. Morphological changes of the cell lines were also examined by invert microscope. Statistical analysis was performed using t-test in GraphPad Prism 8.0.2 software. The results of the study indicate that the phenolic and flavonoid contents of the extract respectively were 14.05 ± 2.39 µgGAE/mg and 39.08 ± 8.78 µgQE/mg. The monovalent reducing power of the extract was 243.32 ± 27.86 μmol Fe2+/g and its total radical scavenging activity (in 1000 µg/ml) was 18.75 ± 1.51 %. The cytotoxic effects of the extract on MDA-MB-231 were higher than MCF7 cell line, significantly (P <0.05). The IC50 value of the extract on MDA-MB-231 and MCF7 cells respectively was 634.5 and 826.8 µg/ml, after 72 hours of incubation. The morphological changes of treated cell line include cell granulation, cell contraction and rupture in a concentration and time dependent pattern. The cytotoxic effects of Hypnea musiformis extract were not dependent on estrogen, progesterone and HER2 receptors. Therefore, the hydromethanolic extract of Hypnea musiformis probably is a favorable option in drug discovery against the triple-negative tumors.